Scientists at the University of Würzburg have uncovered new details about how the immune system works, which are important in enabling the body to remember previous infections. These findings could help to improve immunotherapy for the treatment of cancer.
“Once the body has successfully fought off and eliminated a pathogen, most of the T cells that had previously proliferated die off, as they are no longer needed,” explains Wolfgang Kastenmüller. However, around five to ten per cent of these cells survive and develop into a permanent ‘memory population’ that can protect against future infections. In their study, the researchers have now identified a transcription factor called BATF3, which specifically regulates the survival of these cells and thus the transition to a memory response.
As their experiments demonstrated, this factor is produced only shortly after the initial activation of the T cells. If, however, it is absent, the memory response is permanently disrupted.
“Until now, it was not clear what role this factor plays in so-called CD8+ T cells,” said Kastenmüller. However, when the researchers increased the expression of this factor in CD8+ T cells, it became apparent that their survival – and consequently their immunological memory – was significantly improved.
These findings could help to develop better therapies for treating cancer that utilise the patient’s own immune system – so-called CAR-T cell therapies. Currently, CAR-T cells are being used very successfully, for example, to treat B-cell lymphomas, a malignant disease of the lymphatic system. The researchers therefore plan to modify these CAR-T cells to improve their survival in patients and thus increase their therapeutic efficacy.
References:
University of Würzburg https://www.uni-wuerzburg.de/aktuelles/pressemitteilungen/single/news/gedaechtnistraining-fuer-das-immunsystem/
BATF3 programmes CD8+ T cell memory. Nature Immunology, 28 September 2020. https://www.nature.com/articles/s41590-020-0786-2